NCT02182570View on ClinicalTrials.gov

WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

February 28, 2002

Conditions
Dermatitis, Atopic
Interventions
DRUG

WAL 801 CL dry syrup

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY